{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T15:12:48Z","timestamp":1783177968389,"version":"3.54.6"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s00415-025-13096-y","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T09:28:36Z","timestamp":1744882116000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prodromal seizures in anti-MOG and anti-CASPR2 antibody co-positivity: a case report"],"prefix":"10.1007","volume":"272","author":[{"given":"Vittorio","family":"Viti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Cutillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Zanetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Rocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5485-0479","authenticated-orcid":false,"given":"Massimo","family":"Filippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"issue":"14","key":"13096_CR1","doi-asserted-by":"publisher","first-page":"1137998","DOI":"10.3389\/fneur.2023.1137998","volume":"28","author":"O Corbali","year":"2023","unstructured":"Corbali O, Chitnis T (2023) Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease. Front Neurol 28(14):1137998. https:\/\/doi.org\/10.3389\/fneur.2023.1137998. (PMID:36925938;PMCID:PMC10011114)","journal-title":"Front Neurol"},{"issue":"13","key":"13096_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.885218","volume":"17","author":"E Sechi","year":"2022","unstructured":"Sechi E, Cacciaguerra L, Chen JJ, Mariotto S, Fadda G, Dinoto A, Lopez-Chiriboga AS, Pittock SJ, Flanagan EP (2022) Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): a review of clinical and MRI features, diagnosis, and management. Front Neurol 17(13):885218. https:\/\/doi.org\/10.3389\/fneur.2022.885218. (PMID: 35785363)","journal-title":"Front Neurol"},{"key":"13096_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102011","volume":"41","author":"T Foiadelli","year":"2020","unstructured":"Foiadelli T, Gastaldi M, Scaranzin S, Franciotta D, Savasta S (2020) Seizures and myelin oligodendrocyte glycoprotein (MOG) antibodies: two paradigmatic cases and a review of the literature. Mult Scler Relat Disord 41:102011. https:\/\/doi.org\/10.1016\/j.msard.2020.102011. (Epub 2020 Feb 22 PMID: 32163756)","journal-title":"Mult Scler Relat Disord"},{"issue":"8","key":"13096_CR4","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1177\/1352458520951046","volume":"27","author":"A Kunchok","year":"2021","unstructured":"Kunchok A, Flanagan EP, Krecke KN, Chen JJ, Caceres JA, Dominick J, Ferguson I, Kinkel R, Probasco JC, Ruvalcaba M, Santoro JD, Sieloff K, Timothy J, Weinshenker BG, McKeon A, Pittock SJ (2021) MOG-IgG1 and co-existence of neuronal autoantibodies. Mult Scler 27(8):1175\u20131186. https:\/\/doi.org\/10.1177\/1352458520951046. (Epub 2020 Sep 10. PMID: 32907470; PMCID: PMC8454216)","journal-title":"Mult Scler"},{"issue":"3","key":"13096_CR5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/ana.24117","volume":"75","author":"MJ Titulaer","year":"2014","unstructured":"Titulaer MJ, H\u00f6ftberger R, Iizuka T, Leypoldt F, McCracken L, Cellucci T, Benson LA, Shu H, Irioka T, Hirano M, Singh G, Cobo Calvo A, Kaida K, Morales PS, Wirtz PW, Yamamoto T, Reindl M, Rosenfeld MR, Graus F, Saiz A, Dalmau J (2014) Overlapping demyelinating syndromes and anti\u2013N-methyl-D-aspartate receptor encephalitis. Ann Neurol 75(3):411\u2013428. https:\/\/doi.org\/10.1002\/ana.24117. (PMID:24700511;PMCID:PMC4016175)","journal-title":"Ann Neurol"},{"issue":"8","key":"13096_CR6","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1016\/j.mayocp.2021.02.019","volume":"96","author":"B Chen","year":"2021","unstructured":"Chen B, Lopez Chiriboga AS, Sirven JI, Feyissa AM (2021) Autoimmune encephalitis-related seizures and epilepsy: diagnostic and therapeutic approaches. Mayo Clin Proc 96(8):2029\u20132039. https:\/\/doi.org\/10.1016\/j.mayocp.2021.02.019. (PMID: 34353466)","journal-title":"Mayo Clin Proc"},{"issue":"13","key":"13096_CR7","doi-asserted-by":"publisher","first-page":"175628642096946","DOI":"10.1177\/1756286420969462","volume":"29","author":"P Liu","year":"2020","unstructured":"Liu P, Bai M, Yan X, Ren K, Ding J, Zhao D, Li H, Yan Y, Guo J (2020) Possible coexistence of MOG-IgG-associated disease and anti-Caspr2 antibody-associated autoimmune encephalitis: a first case report. Ther Adv Neurol Disord 29(13):1756286420969462. https:\/\/doi.org\/10.1177\/1756286420969462. (PMID:33193815;PMCID:PMC7605028)","journal-title":"Ther Adv Neurol Disord"},{"key":"13096_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s41983-023-00632-8","volume":"59","author":"S Das","year":"2023","unstructured":"Das S, Pandit A, Ray BK et al (2023) Sentinel seizure heralding Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease. Egypt J Neurol Psychiatry Neurosurg 59:31. https:\/\/doi.org\/10.1186\/s41983-023-00632-8","journal-title":"Egypt J Neurol Psychiatry Neurosurg"},{"key":"13096_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.seizure.2022.04.001","volume":"98","author":"K Tokumoto","year":"2022","unstructured":"Tokumoto K, Nishida T, Kawaguchi N, Kaneko K, Takahashi T, Takahashi Y (2022) Electroclinical features of seizures in myelin oligodendrocyte glycoprotein antibody-associated cerebral cortical encephalitis: a case report and literature review. Seizure 98:13\u201318. https:\/\/doi.org\/10.1016\/j.seizure.2022.04.001. (Epub 2022 Apr 3 PMID: 35397246)","journal-title":"Seizure"},{"key":"13096_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2019.101500","volume":"38","author":"H Uchigami","year":"2020","unstructured":"Uchigami H, Arai N, Sekiguchi M, Ogawa A, Yasuda T, Seto A, Takahashi T, Takeuchi S (2020) Anti-myelin oligodendrocyte glycoprotein antibody-positive acute disseminated encephalomyelitis mimicking limbic encephalitis: a case report. Mult Scler Relat Disord 38:101500. https:\/\/doi.org\/10.1016\/j.msard.2019.101500. (Epub 2019 Nov 5 PMID: 31733424)","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"13096_CR11","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.braindev.2021.10.011","volume":"44","author":"T Horita","year":"2022","unstructured":"Horita T, Inoue T, Kuki I, Nagase S, Yamamoto N, Yamada N, Oki K, Nukui M, Okazaki S, Amo K, Kawawaki H, Sakuma H, Togawa M (2022) A case of bilateral limbic and recurrent unilateral cortical encephalitis with anti-myelin oligodendrocyte glycoprotein antibody positivity. Brain Dev 44(3):254\u2013258. https:\/\/doi.org\/10.1016\/j.braindev.2021.10.011. (Epub 2021 Nov 18 PMID: 34802814)","journal-title":"Brain Dev"},{"issue":"4","key":"13096_CR12","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000353.PMID:28680914;PMCID:PMC5489139","volume":"4","author":"AM Feyissa","year":"2017","unstructured":"Feyissa AM, L\u00f3pez Chiriboga AS, Britton JW (2017) Antiepileptic drug therapy in patients with autoimmune epilepsy. Neurol Neuroimmunol Neuroinflamm 4(4):e353. https:\/\/doi.org\/10.1212\/NXI.0000000000000353.PMID:28680914;PMCID:PMC5489139","journal-title":"Neurol Neuroimmunol Neuroinflamm"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13096-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13096-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13096-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T12:42:02Z","timestamp":1747658522000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13096-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["13096"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13096-y","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]},"assertion":[{"value":"2 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"V. Viti: nothing to disclose. G. Cutillo: nothing to disclose. M. Rubin: nothing to disclose. C. Zanetta received compensation for speaking activities, and\/or consulting services, from Alexion, Astrazeneca, Biogen, Bristol Myers Squibb, Janssen, Merck, Novartis, Roche, Sanofi. M.A. Rocca received consulting fees from Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche; and speaker honoraria from AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck-Serono SpA, Novartis, Roche, Sanofi and Teva. She receives research support from the MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla. She is Associate Editor for Multiple Sclerosis and Related Disorders; and Associate Co-Editor for Europe and Africa for Multiple Sclerosis Journal. M. Filippi is Editor-in-Chief of the Journal of Neurology, Associate Editor of Human Brain Mapping, Neurological Sciences, and Radiology; received compensation for consulting services from Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi; speaking activities from Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA; participation in Advisory Boards for Alexion, Biogen, Bristol Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda; scientific direction of educational events for Biogen, Merck, Roche, Celgene, Bristol Myers Squibb, Lilly, Novartis, Sanofi-Genzyme; he receives research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The present study was conducted in accordance to the Helsinki Declaration (Fortaleza revision, 2013) and with European and Italian regulations about privacy. Patient gave informed consent to study inclusion and to publication of the case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"342"}}